Sin Gon Kim Selected Research

HDL Cholesterol

1/2024	Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review.
1/2023	Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial.
2/2017	Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by 18F-fluorodeoxyglucose positron emission tomography.
1/2015	Implications of Pericardial, Visceral and Subcutaneous Adipose Tissue on Vascular Inflammation Measured Using 18FDG-PET/CT.
2/2013	Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease.
8/2011	Combined effect of high-normal blood pressure and low HDL cholesterol on mortality in an elderly Korean population: the South-West Seoul (SWS) study.
3/2010	Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sin Gon Kim Research Topics

Disease

39	Type 2 Diabetes Mellitus (MODY) 05/2024 - 11/2011
22	Insulin Resistance 01/2023 - 03/2010
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2011
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 03/2006
11	Non-alcoholic Fatty Liver Disease 07/2021 - 01/2013
11	Inflammation (Inflammations) 01/2020 - 03/2010
10	Atherosclerosis 01/2019 - 03/2006
8	Obesity 01/2018 - 01/2008
6	Dyslipidemias (Dyslipidemia) 05/2024 - 01/2020
6	Neoplasms (Cancer) 03/2024 - 12/2005
6	Ischemic Stroke 11/2023 - 01/2018
6	Chronic Kidney Failure (Chronic Renal Failure) 08/2023 - 01/2019
5	Heart Failure 01/2024 - 11/2019
5	Body Weight (Weight, Body) 01/2024 - 09/2018
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2005
4	Diabetes Mellitus 08/2023 - 01/2017
4	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 03/2013
4	Glucose Intolerance 01/2023 - 03/2010
4	Myocardial Infarction 09/2022 - 01/2018
4	Diabetes Complications 01/2021 - 05/2015
4	Albuminuria 01/2021 - 01/2018
3	Weight Gain 01/2024 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 11/2019
3	Dementia (Dementias) 11/2022 - 01/2019
3	Hypertension (High Blood Pressure) 12/2021 - 01/2020
3	Abdominal Obesity 11/2021 - 01/2013
3	Stroke (Strokes) 01/2020 - 06/2019
3	Hypothyroidism 05/2019 - 10/2016
2	Graves Disease (Basedow Disease) 03/2024 - 03/2013
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 01/2023
2	Hypertriglyceridemia 01/2024 - 11/2021
2	Acromegaly 10/2023 - 08/2023
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2023 - 01/2019
2	Atrial Fibrillation 08/2023 - 01/2019
2	Obstructive Sleep Apnea 08/2023 - 12/2013
2	Osteoporosis 09/2022 - 09/2015
2	Chronic Renal Insufficiency 01/2022 - 02/2021
2	Prediabetic State (Prediabetes) 02/2021 - 03/2006
2	Hyperthyroidism 01/2021 - 03/2013
2	Vitamin D Deficiency 11/2015 - 09/2015
2	Atherosclerotic Plaque (Atheroma) 03/2013 - 01/2011
1	Drug-Related Side Effects and Adverse Reactions 05/2024
1	Weight Loss (Weight Reduction) 01/2024
1	Heart Diseases (Heart Disease) 11/2023

Drug/Important Bio-Agent (IBA)

30	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 03/2010
13	C-Reactive ProteinIBA 10/2018 - 03/2010
11	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 05/2015
11	Triglycerides (Triacylglycerol)IBA 01/2024 - 03/2010
8	Insulin (Novolin)FDA Link 04/2024 - 01/2016
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 11/2011
7	HDL CholesterolIBA 01/2024 - 03/2010
7	LipidsIBA 11/2023 - 01/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2006
7	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 07/2014
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 05/2015
5	CreatinineIBA 08/2023 - 02/2017
5	CholesterolIBA 08/2023 - 01/2019
5	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2018
5	EnzymesIBA 01/2023 - 09/2013
5	Vitamin D FDA LinkGeneric 01/2023 - 01/2013
5	LDL CholesterolIBA 01/2022 - 01/2011
5	Indicators and Reagents (Reagents)IBA 12/2021 - 05/2014
5	AdiponectinIBA 02/2013 - 03/2006
4	Blood Glucose (Blood Sugar)IBA 04/2024 - 11/2011
4	Fenofibrate (CiL)FDA LinkGeneric 01/2024 - 01/2019
4	omega-Chloroacetophenone (Mace)IBA 11/2023 - 01/2022
4	IodineIBA 01/2023 - 03/2013
4	lobeglitazoneIBA 10/2020 - 01/2014
4	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019 - 05/2017
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 10/2019
3	AlbuminsIBA 01/2022 - 01/2005
3	Chemotactic FactorsIBA 01/2017 - 09/2015
3	hydroxide ionIBA 11/2015 - 01/2013
3	LC15-0444IBA 11/2015 - 07/2014
3	AdipokinesIBA 01/2012 - 04/2011
2	oxidized low density lipoproteinIBA 05/2024 - 01/2022
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2024 - 10/2020
2	CalciumIBA 01/2023 - 09/2022
2	ImmunosorbentsIBA 01/2023 - 02/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021 - 11/2011
2	TransferasesIBA 01/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2010
2	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2019 - 10/2016
2	Alanine Transaminase (SGPT)IBA 10/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2015
2	alpha-2-HS-GlycoproteinIBA 09/2018 - 01/2018
2	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2017 - 06/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 10/2016 - 10/2016
2	Thyroid HormonesIBA 10/2016 - 12/2015
2	JNK Mitogen-Activated Protein KinasesIBA 11/2015 - 09/2015
2	25-hydroxyvitamin DIBA 09/2015 - 01/2013
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2015 - 07/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015 - 01/2011
1	Atorvastatin (Lipitor)FDA Link 05/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024
1	semaglutideIBA 01/2024

Therapy/Procedure

16	Therapeutics 05/2024 - 03/2010
5	Glycemic Control 01/2023 - 05/2015
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 11/2019
1	Injections 04/2024